HIV :: Phase III trials of cellulose sulfate microbicide for HIV prevention closed

CONRAD, a reproductive health research organization, announced today that it has halted a Phase III clinical trial of cellulose sulfate — a topical microbicide gel being tested for HIV prevention in women — because preliminary results indicated that cellulose sulfate could lead to an increased risk of HIV infection in women who use the compound.

Gardasil :: HPV vaccine now standard of care for Canadian women and girls

The Society of Gynecologic Oncologists of Canada (GOC) applauds the recommendation by the National Advisory Committee on Immunization (NACI) that all Canadian girls and women aged 9 to 26 should be routinely vaccinated with GARDASIL to protect them against the Human Papillomavirus (HPV), the primary cause of cervical cancer.

Obesity :: Esophageal cancer rates climb with obesity

The rapidly climbing obesity rates in the United States have created a higher risk of esophageal cancer linked to reflux disease. And this has some surgeons wondering if a currently popular procedure to remove the esophagus is as safe in obese patients.

HIV :: HIV Dementia alarmingly high in Africa

An international study led by Johns Hopkins suggests that the rate of HIV-associated dementia is so high in sub-Saharan Africa that HIV dementia along with Alzheimer?s disease and dementia from strokes may be among the most common forms of dementia in the world.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack